We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test Differentiates Bacterial and Viral Infections in Febrile Infants

By LabMedica International staff writers
Posted on 29 Sep 2026

Fever in infants younger than 3 months is treated as a medical emergency because infections can become life-threatening while the immune system is still developing. More...

Emergency department teams must quickly distinguish serious bacterial infections that require antibiotics from viral illnesses that usually need monitoring and supportive care. To support this early differentiation, a new blood test uses paired immune-cell markers to help distinguish bacterial from viral infection in febrile newborns.

The investigational test compares the blood levels of CD64 and CD169, two molecules that rise in response to different infection types. CD64 is found on neutrophils, a type of white blood cell, and is thought to increase in bacterial infection. CD169 is found on monocytes, another type of white blood cell, and is thought to increase in viral infection.

Researchers tested blood samples from 60 babies brought to the pediatric emergency department at IRCCS Istituto Giannina Gaslini in Genoa, Italy. Some infants were being assessed and treated for fever, while others were being evaluated for noninfectious conditions. The samples were analyzed using flow cytometry, which enables assessment of individual cell characteristics.

The researchers combined CD64 and CD169 measurements into a ratio for each baby. The average ratio was 1.10 in babies with no infection, 0.33 in babies ultimately confirmed to have a viral infection, and 16.22 in babies confirmed to have a bacterial infection. The test showed 100% sensitivity for bacterial infection and 96.6% specificity, indicating that false positives were very low in this initial cohort.

The research is continuing and is expected to include data on 75 babies. A larger multicenter prospective study, called DISCERN, or Discriminating Infection via Surface CD-marker Expression Ratios iN infancy, is also beginning. That study will assess test accuracy in 300 to 500 babies.

“In very young babies with fever, distinguishing serious bacterial infection from self-limiting viral illness is a major diagnostic dilemma. Our standard biomarkers can help show when there might be a bacterial infection, but they also create 'false positives,' which drives overtreatment. This can mean unnecessary lumbar punctures, antibiotics and hospital admissions for infants who turn out to have only a virus,” said Dr. Tommaso Bellini, pediatric emergency physician at the IRCCS Istituto Giannina Gaslini.

Related Links
IRCCS Istituto Giannina Gaslini


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.